DeZwarteRidder schreef op 20 november 2018 14:09:
Highlights for the Third Quarter of 2018
Record
Company revenues of $2.3 million, a 281% increase year-over-year and a 50% increase quarter-over-quarter.
Among industry-leading revenue per gram equivalent sold to patients of $10.67 per gram.
Sales of high margin derivative products grew rapidly and represented 48% of total patient sales for the quarter, driving robust realized pricing.
20% increase quarter-over-quarter in active registered patients to 4,820 as at September 30, 2018.
Signed five-year supply agreement with Aphria Inc. (“Aphria”), to receive an aggregate of 175,000 kilogram equivalents of high-quality dried cannabis flower and crude cannabis oil at preferred wholesale pricing, commencing in May 2019.
Strategic investment and three-year supply agreement with Natura Naturals Inc. (“Natura”), to receive up to 3,000 kilograms of high-quality cannabis flower per year at preferred wholesale pricing with deliveries to commence in December 2018.
Launch of Symbl, Emblem’s first adult-use recreational cannabis brand.
Signed supply agreements with the Alberta Gaming Cannabis Commission (“AGLC”) and the Ontario Cannabis Store (“OCS”). Fulfilled 100% of commitments to deliver cannabis products before September 30, 2018, which generated $0.8 million in revenues.
Launched oral dose-metered spray, Atmosphere.
Announced strategic partnership with GreenSpace Brands Inc. to develop and commercialize cannabidiol infused health and beauty products for the adult-use recreational market.
Signed five-year supply agreement with and investment in Compass Cannabis Clinic to become a preferred cannabis supplier through its wholly owned subsidiary adult-use retail entity Starbuds Canada.